Casdin Capital as of Sept. 30, 2018
Portfolio Holdings for Casdin Capital
Casdin Capital holds 36 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 7.5 | $62M | 360k | 170.83 | |
| Blueprint Medicines (BPMC) | 7.1 | $59M | 750k | 78.06 | |
| Myokardia | 6.4 | $53M | 805k | 65.20 | |
| Agios Pharmaceuticals (AGIO) | 5.4 | $45M | 580k | 77.12 | |
| Sage Therapeutics (SAGE) | 5.4 | $44M | 312k | 141.25 | |
| Biolife Solutions (BLFS) | 5.2 | $43M | 2.4M | 17.50 | |
| Fate Therapeutics (FATE) | 5.0 | $42M | 2.6M | 16.29 | |
| Invitae (NVTAQ) | 4.9 | $40M | 2.4M | 16.73 | |
| Bluebird Bio | 4.6 | $38M | 258k | 146.00 | |
| Spark Therapeutics | 4.5 | $37M | 675k | 54.55 | |
| Codexis (CDXS) | 4.2 | $35M | 2.0M | 17.15 | |
| Sangamo Biosciences (SGMO) | 4.1 | $34M | 2.0M | 16.95 | |
| Magenta Therapeutics | 3.3 | $27M | 2.3M | 12.01 | |
| Illumina (ILMN) | 3.2 | $26M | 72k | 367.06 | |
| GenMark Diagnostics | 3.1 | $26M | 3.5M | 7.35 | |
| Audentes Therapeutics | 3.0 | $25M | 625k | 39.59 | |
| Alnylam Pharmaceuticals (ALNY) | 2.9 | $24M | 270k | 87.52 | |
| Voyager Therapeutics (VYGR) | 2.6 | $22M | 1.1M | 18.92 | |
| Global Blood Therapeutics In | 2.0 | $17M | 440k | 38.00 | |
| Evolent Health (EVH) | 1.9 | $16M | 550k | 28.40 | |
| Editas Medicine (EDIT) | 1.8 | $15M | 460k | 31.82 | |
| Beigene (ONC) | 1.5 | $12M | 70k | 172.21 | |
| Gritstone Oncology Ord (GRTSQ) | 1.2 | $10M | 721k | 14.24 | |
| Crispr Therapeutics (CRSP) | 1.2 | $9.8M | 220k | 44.35 | |
| Constellation Pharmceticls I | 1.1 | $8.8M | 1.3M | 6.73 | |
| OraSure Technologies (OSUR) | 1.0 | $8.1M | 525k | 15.45 | |
| Homology Medicines | 1.0 | $8.0M | 350k | 22.86 | |
| Clovis Oncology | 0.8 | $6.9M | 235k | 29.37 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $6.5M | 40k | 161.50 | |
| Caredx (CDNA) | 0.7 | $5.8M | 200k | 28.85 | |
| Neogen Corporation (NEOG) | 0.6 | $4.6M | 65k | 71.52 | |
| Celgene Corporation | 0.5 | $4.5M | 50k | 89.50 | |
| Gilead Sciences (GILD) | 0.5 | $3.9M | 50k | 77.22 | |
| Cytomx Therapeutics (CTMX) | 0.5 | $3.8M | 208k | 18.50 | |
| Neon Therapeutics | 0.3 | $2.9M | 338k | 8.54 | |
| Jounce Therapeutics | 0.3 | $2.4M | 375k | 6.50 |
